Trials / Unknown
UnknownNCT02710552
Low-dose Combination of Three Antihypertensive Drugs
Randomized Comparison of Fixed Low-dose Combination of THREE Antihypertensive Drugs Versus Fixed High-dose Combination of Two Antihypertensive Drugs in Arterial Hypertension (the 3D Trial)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University of Roma La Sapienza · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare the efficacy and safety of low-dose combination of three antihypertensive drugs versus fixed high-dose combination of two antihypertensive drugs in arterial hypertension
Detailed description
The aim of the study is to compare the efficacy and safety of commercially available low-dose combination of three antihypertensive drugs versus commercially available fixed high-dose combination of two antihypertensive drugs in arterial hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tripliam (perindopril, indapamide, amlodipine) | Fixed combination of perindopril 5 mg, indapamide 1,25 and amlodipine 5 mg |
| DRUG | Reaptan (perindopril, amlodipine) | Fixed combination of perindopril 10 mg and amlodipine 5 mg |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2019-03-01
- Completion
- 2020-03-01
- First posted
- 2016-03-16
- Last updated
- 2016-03-17
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02710552. Inclusion in this directory is not an endorsement.